Medrx Co., Ltd.'s market cap is currently ¥3.80B. The company's EPS TTM is ¥-18.241; its P/E ratio is ―; Medrx Co., Ltd. is scheduled to report earnings on February 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 29.00M	¥ 59.48M	¥ 8.35M	¥ 115.09M	¥ 169.86M
Gross Profit	¥ 26.00M	¥ 56.86M	¥ 6.09M	¥ 111.18M	¥ 164.61M
Operating Income	¥ -933.00M	¥ -1.10B	¥ -1.06B	¥ -1.13B	¥ -1.63B
EBITDA	¥ -884.52M	¥ -1.05B	¥ -996.66M	¥ -1.05B	¥ -1.59B
Net Income	¥ -932.00M	¥ -1.11B	¥ -1.06B	¥ -1.11B	¥ -1.62B
Balance Sheet
Cash & Short-Term Investments	¥ 1.72B	¥ 994.02M	¥ 1.70B	¥ 1.81B	¥ 1.41B
Total Assets	¥ 2.05B	¥ 1.40B	¥ 2.11B	¥ 2.30B	¥ 2.05B
Total Debt	¥ 0.00	¥ 0.00	¥ 0.00	¥ 50.00M	¥ 0.00
Net Debt	¥ -1.72B	¥ -994.02M	¥ -1.70B	¥ -1.76B	¥ -1.41B
Total Liabilities	¥ 129.00M	¥ 185.56M	¥ 153.10M	¥ 149.88M	¥ 126.83M
Stockholders' Equity	¥ 1.92B	¥ 1.21B	¥ 1.96B	¥ 2.15B	¥ 1.92B
Cash Flow
Free Cash Flow	¥ -913.76M	¥ -1.08B	¥ -926.23M	¥ -1.02B	¥ -1.80B
Operating Cash Flow	¥ -913.00M	¥ -1.07B	¥ -923.69M	¥ -985.35M	¥ -1.55B
Investing Cash Flow	¥ 0.00	¥ -1.96M	¥ -2.54M	¥ -5.10M	¥ -252.34M
Financing Cash Flow	¥ 1.64B	¥ 356.31M	¥ 815.91M	¥ 1.39B	¥ 1.41B

Currency in JPY

Medrx Co., Ltd. Earnings and Revenue History

Income Statement >

Medrx Co., Ltd. Debt to Assets

Balance Sheet >

Medrx Co., Ltd. Cash Flow

Cash Flow >

Medrx Co., Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing